"RIV/61989592:15110/10:10221957" . "cancer; breast; metastatic; advanced; locally; HER2-overexpressing; patients; capecitabine; lapatinib; study; expanded; open-label"@en . "An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer" . . . "15110" . . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "S" . . "anals oncology" . "21" . . "Capri, G." . "The Lapatinib Expanded Access Program (LEAP) was designed to provide access to lapatinib plus capecitabine for HER2-positive metastatic breast cancer patients who previously received an anthracycline, a taxane, and a trastuzumab and had no other treatment options."@en . . . "RIV/61989592:15110/10:10221957!RIV11-MSM-15110___" . . "[C5B41FFAF6A9]" . "The Lapatinib Expanded Access Program (LEAP) was designed to provide access to lapatinib plus capecitabine for HER2-positive metastatic breast cancer patients who previously received an anthracycline, a taxane, and a trastuzumab and had no other treatment options." . . "3" . "Chen, Cs" . . . . "An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer"@en . . "18"^^ . "7"^^ . . . . "Chang, J." . "An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer" . "0923-7534" . . . "Conte, P." . "246262" . . "Cwiertka, Karel" . "An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer"@en . . "1"^^ . .